- GenMark Diagnostics (NASDAQ:GNMK) is exploring a potential sale after getting interest from potential buyers, according to a Bloomberg report.
- GenMark is working with an adviser as it garners interest from other medical diagnostics players, Bloomberg said, citing people familiar.
- Talks are still are at early stage with no guarantee deal will transpire.
- Recall Jan. 11, GenMark Diagnostics provides preliminary Q4 and FY numbers.